COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results
20/03/2019
BERKELEY HEIGHTS, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology
20/03/2019
RTI continues to advance its growing body of clinical evidence for the Fortilink Interbody Fusion Device with TETRAfuse 3D Technology DEERFIELD, Ill., March 20, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. ( [...]
Emerald Health Therapeutics Applauds Government of Canada for Proposing Amendment to Cannabis Excise Tax in Federal Budget
20/03/2019
VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the [...]
Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200
20/03/2019
New Intellectual Property Covers Composition of Matter and Manufacturing Method out to Mid-2030s CRANBURY, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the United [...]
Maryland GI Raises Colorectal Cancer Awareness with Radio Personality Russ Parr
20/03/2019
Colorectal cancer is one of the most prevalent and deadly cancers in the U.S. Capital Digestive Care is spreading the word during Colorectal Cancer Awareness Month that this type of cancer can be prevented ROCKVILLE, Md [...]
New AroCell patent granted by the EPO
20/03/2019
AroCell announced today that the patent nr. 3083698 and titled” Monoclonal Anti-TK1 Antibodies” is granted by European Patent Office and will be published on April 10, 2019 The patent is referring to AroCell’s [...]
CORRECTED VERSION of March 20, 2019 Press Release: New scientific publication from AroCell on TK 210 ELISA in prostate cancer
20/03/2019
In the corrected version of the press release we have added a link to the article. The aim of the study was to investigate the diagnostic value of the AroCell TK 210 ELISA together with free PSA, pro PSA and PHI in [...]
Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019
20/03/2019
Heidelberg, Germany, March 20, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced that it will host a [...]
New scientific publication from AroCell on TK 210 ELISA in prostate cancer
20/03/2019
The aim of the study was to investigate the diagnostic value of the AroCell TK 210 ELISA together with free PSA, pro PSA and PHI in differentiating prostate cancer from benign urological conditions. The study with the [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
20/03/2019
Company Release no. 04/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 20 March 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]
PDMR Dealing
20/03/2019
LONDON, March 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Tiziana Submits IND Application for Oral Formulation of Foralumab for Treatment of NASH
20/03/2019
NEW YORK and LONDON, March 20, 2019 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (the "Company", "Tiziana Life Sciences" or "Tiziana") (NASDAQ: TLSA; AIM: TILS), a US and UK biotechnology company that focuses on the [...]
Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim
20/03/2019
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the U.S. Food & Drug [...]
Herantis Pharma’s Annual Report 2018 published
20/03/2019
Herantis Pharma’s Annual Report 2018 published Herantis Pharma Plc Company release 20 March 2019 at 9:00 am Herantis Pharma Plc’s Annual Report for the year 2018 has been published today. The Annual Report contains [...]
2018 financial results and business update: landmark deal with AstraZeneca to support transition into a fully integrated oncology-focused biotech, strong clinical progress in lead assets
20/03/2019
2018 FINANCIAL RESULTS AND BUSINESS UPDATE: LANDMARK DEAL WITH ASTRAZENECA TO SUPPORT TRANSITION INTO A FULLY INTEGRATED ONCOLOGY-FOCUSED BIOTECH, STRONG CLINICAL PROGRESS IN LEAD ASSETS Cash, cash equivalents and [...]
Resultats annuels 2018 : accord majeur avec AstraZeneca appuyant la transition vers une societe de biotechnologies integree et donnees prometteuses pour les programmes principaux
20/03/2019
La trésorerie, équivalents de trésorerie et actifs financiers [*] s’élèvent à 202,7m€ (millions d’euros) au 31 décembre 2018 (176,6m€ en 2017) Les produits opérationnels s’élèvent à 94,0m€ (36,2m€ en 2017) Les charges [...]
Dermira Prices $130.0 Million Public Offering of Common Stock
20/03/2019
MENLO PARK, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
resTORbio, Inc. Announces Pricing of Public Offering of Common Stock
20/03/2019
BOSTON, March 19, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Abeona Therapeutics annonce ses résultats financiers du quatrième trimestre et de l’exercice complet 2018
19/03/2019
En voie de lancer l'essai clinique VITAL™ de Phase 3 pour le traitement de la RDEB au milieu de 2019 ; EB-101 sera fabriqué en interne Fabrication à l'échelle pour supporter les programmes basés sur AAV ; préparation [...]

Pages